InMed Pharmaceuticals Inc. (INM)

NASDAQ: INM · Real-Time Price · USD

1.490

+0.030 (2.05%)

At close: Aug 4, 2026, 4:00 PM EDT

1.510

+0.020 (1.36%)

After-hours: Aug 4, 2026, 7:17 PM EDT

InMed Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is July - June.

Millions USD. Fiscal year is Jul - Jun.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Market Cap	7	7	2	62	153	512
Market Cap Growth	39.01%	174.82%	-96.16%	-59.65%	-70.14%	-
Enterprise Value	1.78	-3.87	-3.28	53.14	147.48	504.88
Last Close Price	1.49	3.25	5.31	18.54	235.00	1590.00

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
PS Ratio	1.33	1.32	0.51	14.92	140.35	-
PB Ratio	0.70	0.48	0.26	5.10	16.84	69.41
P/TBV Ratio	0.93	0.27	0.27	0.22	0.95	3.38

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
EV/Sales Ratio	0.36	-0.78	-0.71	12.85	135.37	-
EV/EBITDA Ratio	-	0.52	0.43	-	-	-
EV/EBIT Ratio	-	0.49	0.40	-	-	-
EV/FCF Ratio	-	0.50	0.47	-	-	-

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Debt / Equity Ratio	0.00	0.02	0.07	0.00	0.04	0.03
Net Debt / Equity Ratio	-0.69	-0.77	-0.61	-0.71	-0.60	-0.97
Net Debt / EBITDA Ratio	0.52	1.40	0.74	1.09	0.32	0.74
Net Debt / FCF Ratio	0.64	1.34	0.81	1.15	0.35	0.73
Asset Turnover	-	0.36	0.35	0.31	0.10	0
Inventory Turnover	-	2.93	2.44	1.33	0.44	-
Quick Ratio	2.35	6.30	3.53	4.61	1.90	3.35
Current Ratio	3.11	6.99	4.41	5.66	2.89	3.78
Return on Equity (ROE)	-33.88%	-72.10%	-71.95%	-74.84%	-226.07%	-153.95%
Return on Assets (ROA)	-95.93%	-58.00%	-63.16%	-62.56%	-152.99%	-113.04%
Return on Invested Capital (ROIC)	-372.55%	-240.42%	-231.37%	-234.51%	-888.22%	-3404.39%
Return on Capital Employed (ROCE)	-117.21%	-67.37%	-74.66%	-78.12%	-202.71%	-145.17%

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 4, 2026	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Buyback Yield / Dilution	-365.07%	-156.13%	-211.26%	-336.58%	-108.65%	-28.72%
Total Shareholder Return	-365.07%	-156.13%	-211.26%	-336.58%	-108.65%	-28.72%

SEC Filings: 10-K · 10-Q